These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 9604935)

  • 1. Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation.
    Khokhlatchev AV; Canagarajah B; Wilsbacher J; Robinson M; Atkinson M; Goldsmith E; Cobb MH
    Cell; 1998 May; 93(4):605-15. PubMed ID: 9604935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular signal-regulated kinase activates topoisomerase IIalpha through a mechanism independent of phosphorylation.
    Shapiro PS; Whalen AM; Tolwinski NS; Wilsbacher J; Froelich-Ammon SJ; Garcia M; Osheroff N; Ahn NG
    Mol Cell Biol; 1999 May; 19(5):3551-60. PubMed ID: 10207078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimerization in MAP-kinase signaling.
    Cobb MH; Goldsmith EJ
    Trends Biochem Sci; 2000 Jan; 25(1):7-9. PubMed ID: 10637602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase.
    Camps M; Nichols A; Gillieron C; Antonsson B; Muda M; Chabert C; Boschert U; Arkinstall S
    Science; 1998 May; 280(5367):1262-5. PubMed ID: 9596579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation mechanism of the MAP kinase ERK2 by dual phosphorylation.
    Canagarajah BJ; Khokhlatchev A; Cobb MH; Goldsmith EJ
    Cell; 1997 Sep; 90(5):859-69. PubMed ID: 9298898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atomic structure of the MAP kinase ERK2 at 2.3 A resolution.
    Zhang F; Strand A; Robbins D; Cobb MH; Goldsmith EJ
    Nature; 1994 Feb; 367(6465):704-11. PubMed ID: 8107865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest.
    Yen A; Roberson MS; Varvayanis S; Lee AT
    Cancer Res; 1998 Jul; 58(14):3163-72. PubMed ID: 9679985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth factor-induced p42/p44 MAPK nuclear translocation and retention requires both MAPK activation and neosynthesis of nuclear anchoring proteins.
    Lenormand P; Brondello JM; Brunet A; Pouysségur J
    J Cell Biol; 1998 Aug; 142(3):625-33. PubMed ID: 9700154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and biological functions of the N-terminal, noncatalytic domain of extracellular signal-regulated kinase 2.
    Eblen ST; Catling AD; Assanah MC; Weber MJ
    Mol Cell Biol; 2001 Jan; 21(1):249-59. PubMed ID: 11113199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear shuttling of mitogen-activated protein (MAP) kinase (extracellular signal-regulated kinase (ERK) 2) was dynamically controlled by MAP/ERK kinase after antigen stimulation in RBL-2H3 cells.
    Furuno T; Hirashima N; Onizawa S; Sagiya N; Nakanishi M
    J Immunol; 2001 Apr; 166(7):4416-21. PubMed ID: 11254696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel regulatory mechanism of MAP kinases activation and nuclear translocation mediated by PKA and the PTP-SL tyrosine phosphatase.
    Blanco-Aparicio C; Torres J; Pulido R
    J Cell Biol; 1999 Dec; 147(6):1129-36. PubMed ID: 10601328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear translocation of mitogen-activated protein kinase p42MAPK during the ongoing cell cycle.
    Hulleman E; Bijvelt JJ; Verkleij AJ; Verrips CT; Boonstra J
    J Cell Physiol; 1999 Sep; 180(3):325-33. PubMed ID: 10430172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different domains of the mitogen-activated protein kinases ERK3 and ERK2 direct subcellular localization and upstream specificity in vivo.
    Robinson MJ; Xu Be BE; Stippec S; Cobb MH
    J Biol Chem; 2002 Feb; 277(7):5094-100. PubMed ID: 11741894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CGP 41251 and tamoxifen selectively inhibit mitogen-activated protein kinase activation and c-Fos phosphoprotein induction by substance P in human astrocytoma cells.
    Luo W; Sharif TR; Houghton PJ; Sharif M
    Cell Growth Differ; 1997 Nov; 8(11):1225-40. PubMed ID: 9372245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase.
    Fox T; Coll JT; Xie X; Ford PJ; Germann UA; Porter MD; Pazhanisamy S; Fleming MA; Galullo V; Su MS; Wilson KP
    Protein Sci; 1998 Nov; 7(11):2249-55. PubMed ID: 9827991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of the MAP kinase ERK2 is controlled by a flexible surface loop.
    Zhang J; Zhang F; Ebert D; Cobb MH; Goldsmith EJ
    Structure; 1995 Mar; 3(3):299-307. PubMed ID: 7540485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitogen-activated protein kinase translocates to the nucleus during ischaemia and is activated during reperfusion.
    Mizukami Y; Yoshida Ki
    Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):785-90. PubMed ID: 9169613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of GSK3beta reveals a primed phosphorylation mechanism.
    ter Haar E; Coll JT; Austen DA; Hsiao HM; Swenson L; Jain J
    Nat Struct Biol; 2001 Jul; 8(7):593-6. PubMed ID: 11427888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of ERK activation attenuates endothelin-stimulated airway smooth muscle cell proliferation.
    Whelchel A; Evans J; Posada J
    Am J Respir Cell Mol Biol; 1997 May; 16(5):589-96. PubMed ID: 9160841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The structure of phosphorylated p38gamma is monomeric and reveals a conserved activation-loop conformation.
    Bellon S; Fitzgibbon MJ; Fox T; Hsiao HM; Wilson KP
    Structure; 1999 Sep; 7(9):1057-65. PubMed ID: 10508788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.